Mila Bell

Founded in 1986, Celestia Laboratories is an industry leader at the forefront of pharmaceutical innovation and cutting-edge science. Under the guidance of their Founder and benefactor, Mr. Eugine Seong-Hun, as well as Lead Researchers and senior partners, Dr. Ephram Bell, Ph.D., and Dr. Jiaying Lee, Ph.D. has been making waves in the Pharmaceutical industry with their patented 'No-Poke' injection delivery system, and their advances and numerous achievements, at the forefront of neurological science and medicine.

Specializing in elevating the human condition through Neurological stimulation, impulse therapies, and highly sought-after designer pharmaceuticals, Celestia Laboratories has made a name for itself as the International Industry leader in research and cures for all the major diseases that plague humanity, all through the cultivated power of the mind. Largely heralded as heroes of humankind, an image they happily foster for themselves in the media eye, though there may be more to it than first meets the eye.

Rumors have it, located far below the gleaming, publically accessible Celestia Headquarters skyscraper, is a subbasement where testing and research of a different sort takes place. Shrouded in secrecy, no one can say for certain, but multiple instances of unexplainable phenomena in the surrounding area have begun to draw curiosity, speculation and suspicion in recent years.

Subject Designation: 42
Subject Name: Mila Bell
Testing Notes: Subject 42 was injected with Experimental drug Nephalim-4 in utero and was brought into observation immediately following her birth. Results very promising, multiple phenomena observed. Experimenting with electrical impulse, sensory deprevation, chemical cocktails, and subliminal messaging to increase the initial affects with significant success.
Phenomema Observed: Telepathic Empathy, telekenisis, moments of precognition and Astral projection. Phenomena response seems to vary in strength dependant on the subject's emotional state.
Status: Unstable - Fully contained. Held at Celestia Laboratories.
Project Leader: Dr. Ephram Bell.